Procter & Gamble (NYSE:PG – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 6.910-7.050 for the period, compared to the consensus estimate of 6.930. The company issued revenue guidance of $85.7 billion-$87.4 billion, compared to the consensus revenue estimate of $85.2 billion. Procter & Gamble also updated its FY25 guidance to $6.91-$7.05 EPS.
Procter & Gamble Stock Up 0.9 %
Shares of NYSE PG opened at $166.20 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.55. The firm’s 50-day moving average is $168.97 and its two-hundred day moving average is $169.38. Procter & Gamble has a 12-month low of $152.06 and a 12-month high of $180.43. The company has a market capitalization of $391.41 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 3.69 and a beta of 0.45.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. The business had revenue of $21.88 billion for the quarter, compared to analysts’ expectations of $21,657,595.49 billion. During the same quarter last year, the firm earned $1.84 earnings per share. The business’s revenue was up 2.1% on a year-over-year basis. Equities analysts anticipate that Procter & Gamble will post 6.94 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
Analysts Set New Price Targets
A number of equities analysts have weighed in on PG shares. Barclays increased their price target on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research note on Thursday. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Wells Fargo & Company raised their price target on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a report on Thursday. Finally, UBS Group decreased their price objective on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $180.25.
Read Our Latest Stock Analysis on PG
Insider Buying and Selling
In related news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company’s stock.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Golden Cross Stocks: Pattern, Examples and Charts
- Despite Short-Term Risks Freeport McMoran Worth a Look
- What does consumer price index measure?
- 3 Lean and Mean Stocks Generating Over $1M in Revenue Per Worker
- Compound Interest and Why It Matters When Investing
- The Next Big Thing in AI: 2 Edge Computing Chipmakers to Watch
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.